Filing Details

Accession Number:
0001012975-14-000138
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-05 17:18:33
Reporting Period:
2014-03-03
Filing Date:
2014-03-05
Accepted Time:
2014-03-05 17:18:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1177648 Enanta Pharmaceuticals Inc ENTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1106929 Tvm Iv Gmbh & Co Kg C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1133921 Helmut Schuhsler C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1133935 Tvm Medical Ventures Gmbh & Co Kg C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1183073 Tvm V Life Science Ventures Gmbh & Co Kg C/O Tvm Capital Croup
Ottostrasse 4
Munich 2M 80333
No No Yes No
1342938 Tvm V Life Science Ventures Management Gmbh & Co. Kg C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1342939 Gmbh Capital Tvm C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1342940 Tvm Iv Management Gmbh & Co. Kg C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1397372 Alexandra Goll C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1398596 Stefan Fischer C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
1398598 Hubert Birner C/O Tvm Capital Group
Ottostrasse 4
Munich 2M 80333
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-03 1,402 $38.83 351,635 No 4 S Direct
Common Stock Disposition 2014-03-03 1,874 $38.83 469,929 No 4 S Direct
Common Stock Disposition 2014-03-03 5,795 $38.83 1,453,414 No 4 S Direct
Common Stock Disposition 2014-03-04 66,506 $38.82 285,129 No 4 S Direct
Common Stock Disposition 2014-03-04 88,877 $38.82 381,052 No 4 S Direct
Common Stock Disposition 2014-03-04 274,880 $38.82 1,178,534 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.03, inclusive. Each Reporting Person undertakes to provide to Enanta Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The shares are directly held by TVM Medical Ventures GmbH & Co. KG ("Medical Ventures"), the general partner of which is TVM Capital GmbH ("TVM Capital"), for which Alexandra Goll ("Goll") and Helmut Schuhsler ("Schuhsler"), each members of the investment committee of TVM Capital, share voting and investment authority over the shares held by Medical Ventures with the other members of the investment committee. Each of TVM Capital, Goll and Schuhsler disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
  3. The shares are directly held by TVM IV GmbH & Co. KG ("TVM IV"), the managing limited partner of which is TVM IV Management GmbH & Co. KG ("TVM IV Management"), for which Goll and Schuhsler, each members of the investment committee of TVM IV Management, share voting and investment authority over the shares held by TVM IV with the other members of the investment committee. Each of TVM IV Management, Goll and Schuhsler disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
  4. The shares are directly held by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"), the managing limited partner of which is TVM V Life Science Ventures Management GmbH & Co. KG ("TVM V Management"), for which Hubert Birner ("Birner"), Stefan Fischer ("Fischer"), Goll and Schuhsler, each members of the investment committee of TVM V Management, share voting and investment authority over the shares held by TVM V. Each of TVM V Management, Birner, Fischer, Goll and Schuhsler disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.62, inclusive. Each Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.